semaglutide affect liver (Ozempic/Wegovy) dramatically improves fatty disease Wegovy Treated Severe Liver Disease

There are no easy answers for people who cannot afford a GLP-1 drug but remain desperate to lose weight or maintain their weight loss

Even though we confirmed that astrocyte activation induces lactate release in the extracellular space, we cannot exclude that other mechanisms might be activated by optogenetic stimulation of astrocytes

The trade-off is needle-based administration, which some patients refuse or cannot tolerate

Tirzepatide (Zepbound) has shown the highest average weight loss in trials, at up to 21%, compared to about 14 to 18% for semaglutide (depending on form and dose) and 11% for oral orforglipron